FiberSense to bring new CGM to European market with CE mark

FiberSense Continuous Glucose Monitoring (CGM) System obtains CE mark as commercial launch preparations begin

Major regulatory milestone paves the way for commercialization and marks first step toward broader CxM biomarker sensing strategy BASEL, Switzerland, June 17, 2026 /PRNewswire/ — FiberSense AG (“FiberSense”) today announced that the FiberSense Continuous Glucose Monitoring (CGM) System has obtained CE marking under Regulation (EU) 2017/745 as a Class IIb medical device. The system is […] The post FiberSense Continuous Glucose Monitoring (CGM) Sy…

FiberSense to bring new CGM to European market with CE mark

The FiberSense sensor works to continuously monitor glucose. [Image courtesy of the company]FiberSense announced today that it received CE mark approval for its continuous glucose monitoring (CGM) system. The FiberSense system is intended for the continuous monitoring of blood sugar levels and glucose trends in adults with diabetes. It uses advanced optical sensing technology to measure glucose concentrations in the tissue fluid beneath the skin…